Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 9—September 2013

Plasmodium falciparum Mutant Haplotype Infection during Pregnancy Associated with Reduced Birthweight, Tanzania

Daniel T. R. MinjaComments to Author , Christentze Schmiegelow, Bruno Mmbando, Stéphanie Boström, Mayke Oesterholt, Pamela Magistrado, Caroline Pehrson, Davis John, Ali Salanti, Adrian J.F. Luty1, Martha Lemnge, Thor Theander, John Lusingu, and Michael Alifrangis
Author affiliations: National Institute for Medical Research, Tanga Centre, Tanzania (D.T.R. Minja, B. Mmbando, P. Magistrado, M. Lemnge, J. Lusingu); University of Copenhagen, Copenhagen, Denmark (D.T.R. Minja, C. Schmiegelow, P. Magistrado, C. Pehrson, A. Salanti, T. Theander, J. Lusingu, M. Alifrangis); Wenner-Gren Institute, Stockholm, Sweden (S. Boström); Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (M. Oesterholt, A.J.F. Luty); Kilimanjaro Christian Medical Centre, Moshi, Tanzania (D. John)

Main Article

Table 1

Stratification of Plasmodium falciparum mutant haplotypes among pregnant women, by exposure of the women to SP before infection, Korogwe District, Tanga Region, Tanzania, September 2008–October 2010*

Participant exposure to SP No. (%) women with infecting allelic haplotype
Quadruple or less, n = 5 Quintuple, n = 25 Sextuple, n = 24
Did not receive IPTp–SP (n = 28) 4 (14.3) 12 (42.9) 12 (42.9)
Received first dose of IPTp–SP (n = 18) 1 (5.6) 8 (44.4) 9 (50.0)
Received second dose of IPTp–SP (n = 8) 0 5 (62.5) 3 (37.5)
Had previous exposure to SP (n = 30)† 1 (3.3) 16 (53.0) 13 (43.0)

*SP, sulfadoxine–pyrimethamine; IPTp–SP, intermittent preventive treatment during pregnancy with SP.
†Received IPTp-SP or SP used as treatment for malaria before study inclusion.

Main Article

1Current affiliation: Mère et Enfant Face aux Infections Tropicales, Paris, France.

Page created: July 23, 2013
Page updated: August 20, 2013
Page reviewed: August 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.